We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-3.05%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$115M
AUM Growth
+$2.89M
Cap. Flow
+$6.38M
Cap. Flow %
5.57%
Top 10 Hldgs %
17.44%
Holding
188
New
37
Increased
41
Reduced
67
Closed
21

Top Sells

Rank Stock Value
1
STX icon
Seagate
STX
+$957K
2
STT icon
State Street
STT
+$737K
3
AMGN icon
Amgen
AMGN
+$718K
4
BAX icon
Baxter International
BAX
+$688K
5
INTC icon
Intel
INTC
+$685K

Sector Composition

Rank Sector Weight
1 Industrials 25.08%
2 Healthcare 15.79%
3 Energy 14.93%
4 Financials 10.73%
5 Technology 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$618B
$3.08M 2.69%
28,854
-600
-2% -$62.2K
XOM icon
2
ExxonMobil
XOM
$644B
$2.57M 2.24%
27,341
+800
+3% +$79.7K
CHD icon
3
Church & Dwight Co
CHD
$23.4B
$2.57M 2.24%
73,200
-4,400
-6% -$150K
QCOM icon
4
Qualcomm
QCOM
$155B
$2.1M 1.83%
28,115
+5,200
+23% +$398K
GE icon
5
GE Aerospace
GE
$374B
$2.04M 1.78%
16,645
-292
-2% -$36.4K
IHG icon
6
InterContinental Hotels
IHG
$23.9B
$1.71M 1.49%
33,525
+4,471
+15% +$233K
INDB icon
7
Independent Bank
INDB
$3.99B
$1.52M 1.33%
42,647
+10,200
+31% +$376K
CNI icon
8
Canadian National Railway
CNI
$76.9B
$1.5M 1.31%
21,100
-250
-1% -$17.3K
EMR icon
9
Emerson Electric
EMR
$83.9B
$1.45M 1.26%
23,096
+3,650
+19% +$237K
FAST icon
10
Fastenal
FAST
$54.7B
$1.44M 1.26%
128,196
+69,596
+119% +$796K
COP icon
11
ConocoPhillips
COP
$147B
$1.39M 1.21%
18,175
+4,075
+29% +$333K
DINO icon
12
HF Sinclair
DINO
$16.3B
$1.38M 1.21%
31,665
+1,200
+4% +$56K
OXY icon
13
Occidental Petroleum
OXY
$56.8B
$1.33M 1.16%
14,404
+1,096
+8% +$105K
AMGN icon
14
Amgen
AMGN
$208B
$1.3M 1.13%
9,225
-5,500
-37% -$718K
CELG
15
DELISTED
Celgene Corp
CELG
$1.27M 1.11%
13,430
-50
-0.4% -$4.51K
PB icon
16
Prosperity Bancshares
PB
$8.97B
$1.23M 1.07%
21,500
+2,700
+14% +$162K
IBM icon
17
IBM
IBM
$211B
$1.21M 1.06%
6,668
-936
-12% -$171K
TFC icon
18
Truist Financial
TFC
$63.3B
$1.21M 1.06%
32,515
+6,175
+23% +$233K
BNS icon
19
Scotiabank
BNS
$107B
$1.17M 1.02%
20,164
-214
-1% -$13.3K
MRK icon
20
Merck
MRK
$322B
$1.15M 1%
20,264
-943
-4% -$53K
AVT icon
21
Avnet
AVT
$7.29B
$1.14M 1%
27,500
+10,650
+63% +$464K
UL icon
22
Unilever
UL
$137B
$1.13M 0.99%
24,044
KMB icon
23
Kimberly-Clark
KMB
$36.3B
$1.1M 0.96%
10,694
-97
-0.9% -$10.1K
GSK icon
24
GSK
GSK
$104B
$1.09M 0.96%
19,056
+4,880
+34% +$299K
TKR icon
25
Timken Company
TKR
$9.56B
$1.09M 0.95%
25,630
-10,175
-28% -$468K

Similar funds

New England Research & Management's Q3 2014 Portfolio in Review

As of Q3 2014, New England Research & Management held 188 positions worth $115M, up 2.6% from $112M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

New England Research & Management deployed $6.38M of net new capital in Q3 2014, opening 37 new positions and adding to 41 existing holdings. Its largest new stake was Walgreens Boots Alliance: 16,250 shares worth $963K.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was State Street, an estimated $737K trimmed.

  • New England Research & Management's largest Q3 2014 buy was Walgreens Boots Alliance: 16,250 shares worth $963K.
  • New England Research & Management added most to Fastenal in Q3 2014, an estimated $796K increase.
  • New England Research & Management's biggest Q3 2014 reduction was State Street, cutting an estimated $737K.
  • New England Research & Management fully exited Seagate in Q3 2014, selling an estimated $957K.
  • New England Research & Management's ten largest holdings make up 17% of its $115M portfolio in Q3 2014.
  • New England Research & Management opened 37 new positions and closed 21 in Q3 2014.
  • New England Research & Management's portfolio value rose 2.6% quarter-over-quarter to $115M.

Based on New England Research & Management's 13F filing for Q3 2014, filed 15 Oct 2014.